BKL
Click for more information
0.00% $94.73 blackmores limited

Ann: Acquisition of Global Therapeutics-BKL.AX, page-4

  1. kp88
    60 Posts.
    lightbulb Created with Sketch. 2
    clock Created with Sketch.
    06/05/16
    10:05
    Post #: 17692793
    For anyone that's interested, video interview of Christine Holgate and Paul Keogh (Global Therapeutics) about the acquisition. Link below.

    "Blackmores CEO, Christine Holgate and Global Therapeutics Founder, Paul Keogh, talk about the strong strategic and cultural alignment between these two Australian businesses. "

    http://www.abnnewswire.net/press/en/83519/blackmores
    BKL Price at posting: $166.00 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS ASX hits all time high out the gate on Friday trades following bullish US inflation data
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BKL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.